Study S001179

A New Treatment Strategy of Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01006889
Study type: INTERVENTIONAL
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 24
Start: 2008-01
Primary completion: 2009-12
Lead sponsor: University of Florida
Conditions: Nonalcoholic Fatty Liver Disease; Type 2 Diabetes Mellitus
Interventions: DRUG:Exenatide
Results posted: TRUE

Registered primary outcomes

Hepatic Steatosis [6 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.